Cabot Oil & Gas Corporation (NYSE:COG) had its price objective decreased by Barclays from $37.00 to $35.00 in a report released on Tuesday. Barclays currently has an overweight rating on the stock. Cabot Oil & Gas Corporation (NYSE:COG) in last trading activity decreased -1.09% to close at $29.88. Company weekly performance is -7.89% while its quarterly performance stands at -7.00%. Cabot Oil & Gas Corporation (NYSE:COG) is -28.36% away from its 52 week high.
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve amyloid or cell adhesion, on 15 December announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to NEOD001, a novel monoclonal antibody for the potential treatment of AL amyloidosis. This is the first investigational immunotherapy specifically targeting the disease-causing protein in AL amyloidosis to receive Fast Track designation. On last trading day Prothena Corporation plc (NASDAQ:PRTA) advanced 6.16% to close at $21.38. Its volatility for the week is 8.44% while volatility for the month is 7.97%. Prothena Corporation plc (NASDAQ:PRTA) monthly performance is -4.68%.
On December 23, 2014, Roberto Olivo resigned from his position as Executive Director of Operations and Supply of Fuel Systems Solutions, Inc. (NASDAQ:FSYS), effective December 31, 2014 (the “Separation Date”). On last trading day Fuel Systems Solutions, Inc. (NASDAQ:FSYS) decreased -0.09% to close at $11.51. Its volatility for the week is 4.39% while volatility for the month is 4.42%. FSYS’s sales growth for past 5 years was 0.90% and its EPS growth for past 5 years was -15.00%. Fuel Systems Solutions, Inc. (NASDAQ:FSYS) monthly performance is 11.96%.
Shares of CARBO Ceramics Inc. (NYSE:CRR) have earned an average recommendation of “Hold” from the fourteen brokerages that are currently covering the stock, Analyst Ratings.Net reports. Three analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and one has given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $92.51. CARBO Ceramics Inc. (NYSE:CRR) has 0.70% insider ownership while its institutional ownership stands at 92.90%. In last trading activity company’s stock closed at $39.62.
On 12/30/14, Health Care REIT Inc. (NYSE:HCN)’s Series J Cumulative Redeemable Preferred Stock will trade ex-dividend, for its quarterly dividend of $0.4062, payable on 1/15/15. On Friday shares of Health Care REIT, Inc. (NYSE:HCN) closed at $76.79. Company’s sales growth for last 5 years was 45.10% and EPS growth for next 5 years is recorded as 5.70%.